Assertio to acquire Spectrum Pharmaceuticals | Crain's Chicago Business
The all-stock deal would bring oncology drug Rolvedon into Assertio's drug portfolio.
Stay updated with breaking news from Lake Forest Based. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The all-stock deal would bring oncology drug Rolvedon into Assertio's drug portfolio.
/PRNewswire/ -- ATIF Holdings Limited (NASDAQ: ATIF), hereafter referred to as "the Company" or "ATIF," is pleased to announce its recent investment in...
/PRNewswire/ -- ATIF CEO Jun Liu's family charity foundation, Jun & Lina Liu Foundation, has been formally established with a focus on education, environmental...
/PRNewswire/ -- ATIF Holdings Limited (NASDAQ: ATIF, hereafter referred to as "ATIF") hosted its inaugural project roadshow on March 13th, 2023, at its...
OC INSIDER Column by Rick Reiff